Support and advice for clinically extremely vulnerable people

The government has agreed to end the requirement for shielding guidance for people previously considered to be clinically extremely vulnerable.

People previously considered to be clinically extremely vulnerable will not be advised to shield again, as the government agrees to end the requirement for centralised guidance for these groups following expert clinical advice. 

This decision is based on there being far more information available on the virus and what makes individuals more or less vulnerable, the success of the COVID-19 vaccination programme and the emergence of proven treatments, such as dexamethasone and tocilizumab, to support improved outcomes in clinical care pathways.

Get more information on shielding from GOV.UK.

This page was last updated on 20 September 2021

Rate this page